Article
A clinically relevant gene signature in triple negative and basal-like breast cancer
6 Oct 2011
Abstract excerpt
INTRODUCTION: Current prognostic gene expression profiles for breast cancer mainly reflect proliferation status and are most useful in ER-positive cancers. Triple negative breast cancers (TNBC) are clinically heterogeneous and prognostic markers and biology-based therapies are needed to better treat this disease. METHODS: We assembled Affymetrix gene expression data for 579 TNBC and performed unsupervised...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
